Anebulo Pharmaceuticals, Inc.

ANEBOTCHealthcare● Active

$0.36

$-0.01(-3.95%)

Market Cap$14690660

P/E Ratio—

52W High$3.42

52W Low$0.3

Avg Volume10K

Open$0.37

Beta-1.87

Insider Trades Ownership Employees

Anebulo Pharmaceuticals, Inc. (ANEB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ANEB · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Anebulo Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

ANEB insider buying and selling by quarter

ANEB insider selling · ANEB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.3M1.1M0

2022 Q2

2022 Q4

2023 Q1

2023 Q3

2023 Q4

2024 Q1

2024 Q2

2024 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

ANEB executive sell shares · ANEB board member insider trading · ANEB insider trading SEC filing

Showing 4 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Dec 23, 2024	English Aron R. Director	Purchase	10,101,010	$0.99	$10.00M⚡	15,467,300	Form 4
Dec 18, 2023	English Aron R. Director	Gift	300,000	—	—	5,366,290	Form 4
Nov 13, 2023	English Aron R. Director	Award	300,000	—	—	300,000	Form 4
Dec 18, 2023	English Aron R. Director	Gift	300,000	—	—	0	Form 4

English Aron R.

Director

Purchase

Date

Dec 23

10,101,010

Price

$0.99

Value

$10.00M ⚡

View Form 4 on SEC.gov

English Aron R.

Director

Gift

Date

Dec 18

300,000

Price

—

Value

—

View Form 4 on SEC.gov

English Aron R.

Director

Award

Date

Nov 13

300,000

Price

—

Value

—

View Form 4 on SEC.gov

English Aron R.

Director

Gift

Date

Dec 18

300,000

Price

—

Value

—

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ANEB insider trading

ANEB insider trades

Anebulo Pharmaceuticals, Inc. (ANEB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ANEB. Over the past 12 months, 0 insiders have filed transactions with the SEC. ANEB insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Anebulo Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

ANEB insider trading · 5 questions

The insiders of Anebulo Pharmaceuticals, Inc. (ANEB) include executives and directors such as ANEB, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ANEB board member insider tradingwho are ANEB insidersANEB insider rosterAnebulo Pharmaceuticals, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026